Literature DB >> 22806961

Memory performance and fMRI signal in presymptomatic familial Alzheimer's disease.

Meredith N Braskie1, Luis D Medina, Yaneth Rodriguez-Agudelo, Daniel H Geschwind, Miguel Angel Macias-Islas, Paul M Thompson, Jeffrey L Cummings, Susan Y Bookheimer, John M Ringman.   

Abstract

Rare autosomal dominant mutations result in familial Alzheimer's disease (FAD) with a relatively consistent age of onset within families. This provides an estimate of years until disease onset (relative age) in mutation carriers. Increased AD risk has been associated with differences in functional magnetic resonance imaging (fMRI) activity during memory tasks, but most of these studies have focused on possession of apolipoprotein E allele 4 (APOE4), a risk factor, but not causative variant, of late-onset AD. Evaluation of fMRI activity in presymptomatic FAD mutation carriers versus noncarriers provides insight into preclinical changes in those who will certainly develop AD in a prescribed period of time. Adults from FAD mutation-carrying families (nine mutation carriers, eight noncarriers) underwent fMRI scanning while performing a memory task. We examined fMRI signal differences between carriers and noncarriers, and how signal related to fMRI task performance within mutation status group, controlling for relative age and education. Mutation noncarriers had greater retrieval period activity than carriers in several AD-relevant regions, including the left hippocampus. Better performing noncarriers showed greater encoding period activity including in the parahippocampal gyrus. Poorer performing carriers showed greater retrieval period signal, including in the frontal and temporal lobes, suggesting underlying pathological processes.
Copyright © 2012 Wiley Periodicals, Inc.

Entities:  

Keywords:  APP; PSEN1; early onset; functional magnetic resonance imaging; hippocampus; medial temporal lobe; mutation; volume

Mesh:

Substances:

Year:  2012        PMID: 22806961      PMCID: PMC3812259          DOI: 10.1002/hbm.22141

Source DB:  PubMed          Journal:  Hum Brain Mapp        ISSN: 1065-9471            Impact factor:   5.038


  49 in total

1.  Segmentation of brain MR images through a hidden Markov random field model and the expectation-maximization algorithm.

Authors:  Y Zhang; M Brady; S Smith
Journal:  IEEE Trans Med Imaging       Date:  2001-01       Impact factor: 10.048

2.  Temporal autocorrelation in univariate linear modeling of FMRI data.

Authors:  M W Woolrich; B D Ripley; M Brady; S M Smith
Journal:  Neuroimage       Date:  2001-12       Impact factor: 6.556

3.  Under-recruitment and nonselective recruitment: dissociable neural mechanisms associated with aging.

Authors:  Jessica M Logan; Amy L Sanders; Abraham Z Snyder; John C Morris; Randy L Buckner
Journal:  Neuron       Date:  2002-02-28       Impact factor: 17.173

4.  General multilevel linear modeling for group analysis in FMRI.

Authors:  Christian F Beckmann; Mark Jenkinson; Stephen M Smith
Journal:  Neuroimage       Date:  2003-10       Impact factor: 6.556

5.  Hippocampal hyperactivation in presymptomatic familial Alzheimer's disease.

Authors:  Yakeel T Quiroz; Andrew E Budson; Kim Celone; Adriana Ruiz; Randall Newmark; Gabriel Castrillón; Francisco Lopera; Chantal E Stern
Journal:  Ann Neurol       Date:  2010-12       Impact factor: 10.422

6.  Presenilin-1-associated abnormalities in regional cerebral perfusion.

Authors:  K A Johnson; F Lopera; K Jones; A Becker; R Sperling; J Hilson; J Londono; I Siegert; M Arcos; S Moreno; L Madrigal; J Ossa; N Pineda; A Ardila; M Roselli; M S Albert; K S Kosik; A Rios
Journal:  Neurology       Date:  2001-06-12       Impact factor: 9.910

7.  Patterns of brain activation in people at risk for Alzheimer's disease.

Authors:  S Y Bookheimer; M H Strojwas; M S Cohen; A M Saunders; M A Pericak-Vance; J C Mazziotta; G W Small
Journal:  N Engl J Med       Date:  2000-08-17       Impact factor: 91.245

Review 8.  Mild cognitive impairment as a diagnostic entity.

Authors:  R C Petersen
Journal:  J Intern Med       Date:  2004-09       Impact factor: 8.989

Review 9.  Neuropathological stageing of Alzheimer-related changes.

Authors:  H Braak; E Braak
Journal:  Acta Neuropathol       Date:  1991       Impact factor: 17.088

10.  Phases of A beta-deposition in the human brain and its relevance for the development of AD.

Authors:  Dietmar R Thal; Udo Rüb; Mario Orantes; Heiko Braak
Journal:  Neurology       Date:  2002-06-25       Impact factor: 9.910

View more
  5 in total

1.  Impaired default network functional connectivity in autosomal dominant Alzheimer disease.

Authors:  Jasmeer P Chhatwal; Aaron P Schultz; Keith Johnson; Tammie L S Benzinger; Clifford Jack; Beau M Ances; Caroline A Sullivan; Stephen P Salloway; John M Ringman; Robert A Koeppe; Daniel S Marcus; Paul Thompson; Andrew J Saykin; Stephen Correia; Peter R Schofield; Christopher C Rowe; Nick C Fox; Adam M Brickman; Richard Mayeux; Eric McDade; Randall Bateman; Anne M Fagan; Allison M Goate; Chengjie Xiong; Virginia D Buckles; John C Morris; Reisa A Sperling
Journal:  Neurology       Date:  2013-07-24       Impact factor: 9.910

2.  APOE4 Status is Related to Differences in Memory-Related Brain Function in Asymptomatic Older Adults with Family History of Alzheimer's Disease: Baseline Analysis of the PREVENT-AD Task Functional MRI Dataset.

Authors:  Sheida Rabipour; Sricharana Rajagopal; Elsa Yu; Stamatoula Pasvanis; Marie-Elyse Lafaille-Magnan; John Breitner; M Natasha Rajah
Journal:  J Alzheimers Dis       Date:  2020       Impact factor: 4.472

3.  Effects of gene mutation and disease progression on representative neural circuits in familial Alzheimer's disease.

Authors:  Meina Quan; Tan Zhao; Yi Tang; Ping Luo; Wei Wang; Qi Qin; Tingting Li; Qigeng Wang; Jiliang Fang; Jianping Jia
Journal:  Alzheimers Res Ther       Date:  2020-01-14       Impact factor: 6.982

Review 4.  Neural Networks in Autosomal Dominant Alzheimer's Disease: Insights From Functional Magnetic Resonance Imaging Studies.

Authors:  Qiongqiong Qiu
Journal:  Front Aging Neurosci       Date:  2022-07-19       Impact factor: 5.702

5.  PSEN1 c.1292C<A Variant and Early-Onset Alzheimer's Disease: A Scoping Review.

Authors:  Maribel Orozco-Barajas; Yulisa Oropeza-Ruvalcaba; Alejandro A Canales-Aguirre; Victor J Sánchez-González
Journal:  Front Aging Neurosci       Date:  2022-07-22       Impact factor: 5.702

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.